| This week's sponsor is Pfizer CentreOne. | | | Pfizer CentreOne™ is a global CDMO embedded within Pfizer. We focus on custom API synthesis, sterile injectable fill-finish and highly potent oral solid dose; and are a leading supplier of steroid and hormone APIs and intermediates. For more information, visit www.pfizercentreone.com. |
| Welcome to FierceLifeSci Weekly Digest, your roundup of the biggest and most popular stories from each of our publications. | |
|
Featured Story | | | Tuesday, December 5, 2017 It feels as though we say this every year, but it bears repeating: From CEOs and COOs to division chiefs and venture capital partners, women are taking the lead and making an impact all over the life sciences industry. |
|
|
Top Stories Of The Week Wednesday, December 6, 2017 Michael Gilman went into retirement when Bristol-Myers Squibb bought out his Padlock Therapeutics venture last year, but has made a comeback at the helm of a new company promising to transform cell and gene therapies. Monday, December 4, 2017 The market for generic pills has gotten so bad in the U.S. that Novartis is thinking about selling off its oral solids business there, outgoing CEO Joseph Jimenez told analysts. Friday, December 1, 2017 Bayer was keeping mum yesterday on where its R&D vet Andreas Busch, Ph.D., was heading after it announced his exit and a big change-up in its research unit, but early this morning Shire announced he would be joining their company. Monday, December 4, 2017 Pfizer is the smartest company in the Dow. That’s according to Talent Growth Advisors' annual assessment of the 30 companies that make up the Dow Jones Industrial Average. Friday, December 1, 2017 When doctors in Paris treated an HIV-infected lung cancer patient with Bristol-Myers Squibb’s immuno-oncology drug Opdivo (nivolumab), they were stunned to discover a huge decrease in the patient’s viral “reservoirs”—hideaways in the body that allow HIV to escape from antiretroviral treatments. Tuesday, December 5, 2017 On the heels of a new safety alert, the Philippines' FDA ordered Sanofi to pull Dengvaxia from the market. It's the only country where a mass vaccination program is underway. Wednesday, December 6, 2017 In a much-anticipated action, the FDA released its first-ever technical guidance for manufacturers using 3D-printed technology for medical products that include devices, medication and human tissue. Wednesday, December 6, 2017 China’s WuXi Biologics says its new $150 million, 30,000-liter capacity biologics plant is up and running, a feat it accomplished in less than three years. Wednesday, December 6, 2017 Less than three months after coming to life via a merger of Pluriomics and Axiogenesis, human induced pluripotent stem cell expert Ncardia has signed disease-modeling licensing deals with Roche and Evotec. Resources Sponsored by: WCG Selecting the right sites to conduct your clinical trials will determine the success or failure of meeting your enrollment goals. Sponsored by: Deloitte Sourcing research externally seems to be the preferred path for biopharma companies to strengthen their R&D pipeline. Sponsored by: Veeva Systems Read this guide if you’re a global life sciences company - conducting clinical trials across several countries, or manufacturing and distributing products in multiple regions - to learn five steps to align and improve quality oversight, as well as avoid common mistakes in harmonization initiatives. Sponsored by: Veeva Systems Read Deloitte Consulting's whitepaper on the value of a holistic RIM capability, covering the potential cost savings and revenue gains from doing RIM right. Sponsored by: Veeva Systems See the results from one of the largest, most in-depth surveys of clinical data management professionals on data management practices, performance, and challenges. Sponsored by: Veeva Systems Gain a complete, real-time view of quality and streamline operations. Incorporate partners into processes for critical oversight and 30% greater efficiency, and transform cross-functional processes like change control. Presented by: DSM Biomedical Discover DSM's Dyneema Purity® membrane, an effective and efficient material to construct stent grafts used in minimally invasive surgeries to treat both cardiovascular and peripheral arterial diseases. Sponsored by: ePharmaSolutions As clinical trials become more complex, safety document distribution to investigative sites has reached the point that demands a solution. Sponsored by: Ashfield Healthcare December 5, 2017 | 2pm EST / 11am PST Join this webinar to learn methods that maintain and build sales momentum despite turnover. | 